日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

JAK inhibition in PD-1 immunotherapy and tumor microenvironment

PD-1免疫疗法中的JAK抑制及肿瘤微环境

Liu, Ziyuan; Liu, Jiaqi; Chu, Hongyu; Lu, Zhuming; Xu, Shengshan; Qin, Yanguo; Zhao, Lianfang; Zhang, Chi

Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation

基于生物信息学和实验验证,构建并功能验证了与二硫键凋亡相关的肺腺癌预后模型。

Shen, Tao; Lu, Zhuming; Yang, Sisi; Zhang, Dongxi; Ke, Yongwen; Chen, Zhuowen; Wu, Jinqiang; Wu, Weidong

The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis.

PLIN3 在预后和肿瘤相关巨噬细胞浸润中的作用:泛癌分析

Yang Shaohua, Liu Hejie, Zheng Youbin, Chu Hongyu, Lu Zhuming, Yuan Jie, Xu Shengshan

Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses.

二硫键凋亡与肿瘤微环境在癌症中的相互作用:对预后和治疗反应的影响

Xu Shengshan, Chen Zizhou, Chen Xiguang, Chu Hongyu, Huang Xufeng, Chen Chunyu, Liu Hejie, Qu Yuting, Lu Zhuming

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer

靶向T细胞耗竭:非小细胞肺癌的新兴策略

Liu, Xianqiang; Xi, Xiaowei; Xu, Shengshan; Chu, Hongyu; Hu, Penghui; Li, Dong; Zhang, Bin; Liu, Hejie; Jiang, Tianxiao; Lu, Zhuming

Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysis

免疫细胞与肺癌风险之间的因果关系:一项双样本双向孟德尔随机化分析

Xu, Shengshan; Fang, Huiying; Shen, Tao; Zhou, Yufu; Zhang, Dongxi; Ke, Yongwen; Chen, Zhuowen; Lu, Zhuming

Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response

全面的泛癌分析表明,EPHB2 是一种新型的预测性生物标志物,可用于预测预后和免疫治疗反应。

Xu, Shengshan; Zheng, Youbin; Ye, Min; Shen, Tao; Zhang, Dongxi; Li, Zumei; Lu, Zhuming

Multi‑omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma.

基于恶性细胞相关配体受体基因的多组学鉴定肺腺癌特征

Xu Shengshan, Chen Xiguang, Ying Haoxuan, Chen Jiarong, Ye Min, Lin Zhichao, Zhang Xin, Shen Tao, Li Zumei, Zheng Youbin, Zhang Dongxi, Ke Yongwen, Chen Zhuowen, Lu Zhuming

An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants

一种基于mRNA的T细胞诱导抗原可增强COVID-19疫苗对SARS-CoV-2变种的抵抗力

Wanbo Tai # ,Shengyong Feng # ,Benjie Chai # ,Shuaiyao Lu # ,Guangyu Zhao # ,Dong Chen # ,Wenhai Yu # ,Liting Ren ,Huicheng Shi ,Jing Lu ,Zhuming Cai ,Mujia Pang ,Xu Tan ,Penghua Wang ,Jinzhong Lin ,Qiangming Sun ,Xiaozhong Peng ,Gong Cheng

International expert consensus on immunotherapy for early-stage non-small cell lung cancer

关于早期非小细胞肺癌免疫疗法的国际专家共识

Liang, Wenhua; Cai, Kaican; Cao, Qingdong; Chen, Chun; Chen, Haiquan; Chen, Jun; Chen, Ke-Neng; Chen, Qixun; Chu, Tianqing; Dong, Yuchao; Fan, Jiang; Fang, Wentao; Fu, Junke; Fu, Xiangning; Gao, Shugeng; Ge, Di; Geng, Guojun; Geng, Qing; He, Jie; Hu, Jian; Hu, Jie; Hu, Wei-Dong; Jiang, Feng; Jiang, Tao; Jiao, Wenjie; Li, He-Cheng; Li, Qiang; Li, Shanqing; Li, Shuben; Li, Xiangnan; Liao, Yong-De; Liu, Changhong; Liu, Hongxu; Liu, Yang; Lu, Zhuming; Luo, Qingquan; Ma, Haitao; Pan, Xiaojie; Qiao, Guibin; Ren, Shengxiang; Shen, Weiyu; Song, Yong; Sun, Daqiang; Wang, Guangsuo; Wang, Jie; Wang, Mengzhao; Wang, Qiwen; Wang, Wen-Xiang; Wei, Li; Wu, Ming; Wu, Nan; Xia, Hui; Xu, Shi-Dong; Yang, Fan; Yang, Kang; Yang, Yue; Yu, Fenglei; Yu, Zhen-Tao; Yue, Dong-Sheng; Zhang, Lanjun; Zhang, Weidong; Zhang, Zhenfa; Zhao, Guofang; Zhao, Jian; Zhao, Xiaojing; Zhou, Chengzhi; Zhou, Qinghua; Zhu, Kunshou; Zhu, Yuming; Hida, Toyoaki; Dempke, Wolfram C M; Rossi, Antonio; de Perrot, Marc; Ramirez, Robert A; Provencio, Mariano; Lee, Jay M; Passaro, Antonio; Spaggiari, Lorenzo; Spicer, Jonathan; Girard, Nicolas; Forde, Patrick M; Mok, Tony S K; Cascone, Tina; He, Jianxing